Krystal Biotech, Inc. — Director's Dealing 2019

Mar 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2019-03-22

Reporting Person: Riley Antony A (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-22	Stock Option (Right to Buy)	$25.02	A	25000	Acquired	2029-03-22	Common Stock (25000)	Direct

Footnotes

F1: The options were awarded on March 22, 2019 and vest ratably over a four-year period.